Subclinical reactivation of herpes simplex virus type 1 in the oral cavity.
about
Towards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknownHSV-1 DNA in tears and saliva of normal adultsLongitudinal study on oral shedding of herpes simplex virus 1 and varicella-zoster virus in individuals infected with HIVAsymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein BEffect of prophylactic valacyclovir on the presence of human herpesvirus DNA in saliva of healthy individuals after dental treatmentBurning mouth syndrome due to herpes simplex virus type 1Immunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individualsFuture of an "Asymptomatic" T-cell Epitope-Based Therapeutic Herpes Simplex VaccineHSV-1 latent rabbits shed viral DNA into their saliva.Mucosal herpes immunity and immunopathology to ocular and genital herpes simplex virus infections.Current trends in negative immuno-synergy between two sexually transmitted infectious viruses: HIV-1 and HSV-1/2.Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1.Silicone-acyclovir controlled release devices suppress primary herpes simplex virus-2 and varicella zoster virus infections in vitroControlled release delivery of penciclovir via a silicone (MED-4750) polymer: kinetics of drug delivery and efficacy in preventing primary feline herpesvirus infection in culture.Herpes simplex virus reactivation as a trigger of mucous lesions in pemphigus vulgaris.Oral shedding of herpes simplex virus type 1 in immunocompetent persons.Herpes simplex virus type 1 shedding in the oral cavity of seropositive patients.Herpes simplex virus 1 infected neuronal and skin cells differ in their susceptibility to complement attack.Asymptomatic shedding of HSV-1 in patients undergoing oral surgical procedures and attending for noninvasive treatment.
P2860
Q21296712-2D88FA6C-383A-4F11-B53B-A5626078CB90Q24532006-4FD17BAE-3D3C-4B3E-85B9-A77A1466AB0DQ28660303-4E7196F0-1462-4DAD-82C5-D4313A8254C8Q30847945-16523BB0-B5E1-40AE-800C-017A26DF0B5AQ33859097-F13F566C-F138-49EA-8F48-37DBDCCB4A93Q35468084-1DB1EB5A-C2B7-4A0E-8737-83FDC8011AB1Q35868029-C33F0A48-86A5-4FA0-B272-2C401BB70CEEQ36025675-C3BA9F47-4072-4FD8-99DE-7339CC03A19FQ36459433-0AB36F19-2EA9-4CCE-A02A-CD5E3E1B895BQ36520832-B2DD2C15-E53E-460A-BB46-9836AFECC483Q36555158-64E3169D-03F7-4593-A1BC-45280C401684Q37059943-2371EB95-C16A-4C37-9E4C-76172A64FFE4Q37105722-12FFED2D-412E-477E-B82D-4F68657E2820Q37612784-20F82CC0-EAFC-43A6-BFAC-9657D0A64FCBQ42222595-4214F839-9FEE-4FDD-940C-C13B72E7236EQ45412270-453D595E-A622-44FC-8B2C-AEBB94FE80C6Q45527086-04E1F8FF-1BF0-4A88-B347-19396AB68F28Q45731866-57D0C9F6-7423-4A4E-BF97-0D6F70EA06B7Q50897252-5A396F03-601B-4352-B95E-9678CE752C5A
P2860
Subclinical reactivation of herpes simplex virus type 1 in the oral cavity.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Subclinical reactivation of herpes simplex virus type 1 in the oral cavity.
@en
Subclinical reactivation of herpes simplex virus type 1 in the oral cavity.
@nl
type
label
Subclinical reactivation of herpes simplex virus type 1 in the oral cavity.
@en
Subclinical reactivation of herpes simplex virus type 1 in the oral cavity.
@nl
prefLabel
Subclinical reactivation of herpes simplex virus type 1 in the oral cavity.
@en
Subclinical reactivation of herpes simplex virus type 1 in the oral cavity.
@nl
P2093
P1476
Subclinical reactivation of herpes simplex virus type 1 in the oral cavity.
@en
P2093
P304
P356
10.1034/J.1399-302X.2000.150502.X
P577
2000-10-01T00:00:00Z